본문 바로가기
KERD
논문KCI 등재

Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background/Aims: Intrahepatic cholangiocarcinoma (iCCA) with a ductal plate malformation (DPM) pattern is a recently recognized rare variant. The genomic profile of iCCA with DPM pattern needs to be elucidated. Methods: Cases of iCCA with DPM pattern were retrospectively reviewed based on the medical records, pathology slides, and magnetic resonance imaging (MRI) reports collected between 2010 to 2019 at a single center. Massive parallel sequencing was performed for >500 cancerrelated genes. Results: From a total of 175 iCCAs, five (2.9%) cases of iCCA with DPM pattern were identified. All cases were of the small duct type, and background liver revealed chronic B viral or alcoholic hepatitis. Three iCCAs with DPM pattern harbored MRI features favoring the diagnosis of hepatocellular carcinoma, whereas nonspecific imaging features were observed in two cases. All patients were alive without recurrence during an average follow-up period of 57 months. Sequencing data revealed 64 mutated genes in the five cases, among which FGFR2 and PTPRT were most frequently mutated (three cases each) including an FGFR2-TNC fusion in one case. Mutations in ARID1A and CDKN2A were found in two cases, and mutations in TP53, BAP1, ATM, NF1, and STK11 were observed in one case each. No IDH1, KRAS, or PBRM1 mutations were found. Conclusions: iCCAs with DPM pattern have different clinico-radio-pathologic and genetic characteristics compared to conventional iCCAs. Moreover, FGFR2 and ARID1A variants were identified. Altogether, these findings further suggest that iCCA with DPM pattern represents a specific subtype of small duct type iCCA.

Abstract

Background/Aims: Intrahepatic cholangiocarcinoma (iCCA) with a ductal plate malformation (DPM) pattern is a recently recognized rare variant. The genomic profile of iCCA with DPM pattern needs to be elucidated. Methods: Cases of iCCA with DPM pattern were retrospectively reviewed based on the medical records, pathology slides, and magnetic resonance imaging (MRI) reports collected between 2010 to 2019 at a single center. Massive parallel sequencing was performed for >500 cancerrelated genes. Results: From a total of 175 iCCAs, five (2.9%) cases of iCCA with DPM pattern were identified. All cases were of the small duct type, and background liver revealed chronic B viral or alcoholic hepatitis. Three iCCAs with DPM pattern harbored MRI features favoring the diagnosis of hepatocellular carcinoma, whereas nonspecific imaging features were observed in two cases. All patients were alive without recurrence during an average follow-up period of 57 months. Sequencing data revealed 64 mutated genes in the five cases, among which FGFR2 and PTPRT were most frequently mutated (three cases each) including an FGFR2-TNC fusion in one case. Mutations in ARID1A and CDKN2A were found in two cases, and mutations in TP53, BAP1, ATM, NF1, and STK11 were observed in one case each. No IDH1, KRAS, or PBRM1 mutations were found. Conclusions: iCCAs with DPM pattern have different clinico-radio-pathologic and genetic characteristics compared to conventional iCCAs. Moreover, FGFR2 and ARID1A variants were identified. Altogether, these findings further suggest that iCCA with DPM pattern represents a specific subtype of small duct type iCCA.

참고문헌 (42)

  1. Massarweh NN, "Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma", Cancer Control, 24, pp.1073274817729245~ (2017)
  2. Nakanuma Y, "Intrahepatic cholangiocarcinoma with predominant"ductal plate malformation"pattern : a new subtype", Am J Surg Pathol, 36, pp.1629~1635 (2012)
  3. Desmet VJ, "Congenital diseases of intrahepatic bile ducts : variations on the theme"ductal plate malformation"", Hepatology, 16, pp.1069~1083 (1992)
  4. Awasthi A, "Morphological and immunohistochemical analysis of ductal plate malformation : correlation with fetal liver", Histopathology, 45, pp.260~267 (2004)
  5. WHO Classification of Tumours Editorial Board, "Digestive system tumours" (2019), International Agency for Research on Cancer
  6. Jiao Y, "Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas", Nat Genet, 45, pp.1470~1473 (2013)
  7. Farshidfar F, "Integrative genomic analysis of cholangiocarcinoma identifies distinct IDHmutant molecular profiles", Cell Rep, 18, pp.2780~2794 (2017)
  8. Zou S, "Mutational landscape of intrahepatic cholangiocarcinoma", Nat Commun, 5, pp.5696~ (2014)
  9. Lowery MA, "Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas : potential targets for intervention", Clin Cancer Res, 24, pp.4154~4161 (2018)
  10. Goeppert B, "Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma", Hepatology, 69, pp.2091~2106 (2019)
  11. Liau JY, "Morphological subclassification of intrahepatic cholangiocarcinoma : etiological, clinicopathological, and molecular features", Mod Pathol, 27, pp.1163~1173 (2014)
  12. Wang T, "Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma", Hum Pathol, 91, pp.19~25 (2019)
  13. Banales JM, "Cholangiocarcinoma 2020 : the next horizon in mechanisms and management", Nat Rev Gastroenterol Hepatol, 17, pp.557~588 (2020)
  14. "Liver Imaging Reporting and Data System (LI-RADS) version 2018" (2018)[URL]
  15. Bankhead P, "QuPath : open source software for digital pathology image analysis", Sci Rep, 7, pp.16878~ (2017)
  16. Li H, "Fast and accurate short read alignment with Burrows-Wheeler transform", Bioinformatics, 25, pp.1754~1760 (2009)
  17. Dunn T, "Pisces : an accurate and versatile variant caller for somatic and germline nextgeneration sequencing data", Bioinformatics, 35, pp.1579~1581 (2019)
  18. Hayashi A, "Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma", Am J Surg Pathol, 40, pp.1021~1030 (2016)
  19. Sia D, "Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes", Gastroenterology, 144, pp.829~840 (2013)
  20. Rhee H, "Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma", Liver Int, 38, pp.113~124 (2018)
  21. Chung T, "Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes", HPB (Oxford), 22, pp.864~873 (2020)
  22. Rhee H, "A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types : clinicopathologic significance", Eur Radiol, 29, pp.3111~3121 (2019)
  23. Nam JG, "Intrahepatic mass-forming cholangiocarcinoma : relationship between computed tomography characteristics and histological subtypes", J Comput Assist Tomogr, 42, pp.340~349 (2018)
  24. Fujita N, "Mass-forming intrahepatic cholangiocarcinoma : enhancement patterns in the arterial phase of dynamic hepatic CT : correlation with clinicopathological findings", Eur Radiol, 27, pp.498~506 (2017)
  25. Kim SA, "Intrahepatic mass-forming cholangiocarcinomas : enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern : correlation with clinicopathologic findings", Radiology, 260, pp.148~157 (2011)
  26. Nakanuma Y, "Pathological classification of intrahepatic cholangiocarcinoma based on a new concept", World J Hepatol, 2, pp.419~427 (2010)
  27. Banales JM, "Expert consensus document : cholangiocarcinoma : current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma(ENS-CCA)", Nat Rev Gastroenterol Hepatol, 13, pp.261~280 (2016)
  28. Palmer WC, "Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma", J Hepatol, 57, pp.69~76 (2012)
  29. Kasper HU, "Liver tumor infiltrating lymphocytes : comparison of hepatocellular and cholangiolar carcinoma", World J Gastroenterol, 15, pp.5053~5057 (2009)
  30. Kobayashi N, "FOXP3+regulatory T cells affect the development and progression of hepatocarcinogenesis", Clin Cancer Res, 13, pp.902~911 (2007)
  31. Hasita H, "Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma", Cancer Sci, 101, pp.1913~1919 (2010)
  32. Miura T, "Prognostic impact of CD163+ macrophages in tumor stroma and CD8+ T-Cells in cancer cell nests in invasive extrahepatic bile duct cancer", Anticancer Res, 37, pp.183~190 (2017)
  33. Min JH, "Intrahepatic mass-forming cholangiocarcinoma : arterial enhancement patterns at MRI and prognosis", Radiology, 290, pp.691~699 (2019)
  34. Kozaka K, "Dynamic CT findings of cholangiolocellular carcinoma: correlation with angiography-assisted CT and histopathology", Abdom Radiol(NY), 42, pp.861~869 (2017)
  35. Churi CR, "Mutation profiling in cholangiocarcinoma : prognostic and therapeutic implications", PLoS One, 9, pp.e115383~ (2014)
  36. Tsai JH, "S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas", Histopathology, 61, pp.1106~1116 (2012)
  37. Ma B, "Distinct clinical and prognostic implication of IDH1", 2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma, 2020, pp.20, 318~
  38. Kendall T, "Anatomical, histomorphological and molecular classification of cholangiocarcinoma", Liver Int, 39(Suppl 1), pp.7~18 (2019)
  39. Jusakul A, "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma", Cancer Discov, 7, pp.1116~1135 (2017)
  40. Cardinale V, "Intrahepatic cholangiocarcinoma : review and update", Hepatoma Res, 4, pp.20~ (2018)
  41. Lui VW, "Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer", Proc Natl Acad Sci U S A, 111, pp.1114~1119 (2014)
  42. Sasaki M, "Cholangiolocellular carcinoma with"ductal plate malformation"pattern may be characterized by ARID1A genetic alterations", Am J Surg Pathol, 43, pp.352~360 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (19건)